Robert Wynalek Named Chief Operating and Commercialization Officer of Discgenics

Discgenics, a spinal therapeutics company, has appointed Robert M. Wynalek as its chief operating and commercialization officer.

Advertisement

Mr. Wynalek previously served as president at Osteotech prior to its acquisition by Medtronic in late 2010. His other previous leadership experience includes stints at Medtronic Sofamor Danek Group and Smith & Nephew Orthopedics.

More Articles on Executive Moves:

VG Innovations Names John Kippenberger VP of Sales

10 Orthopedic & Spine Device Company Leadership Moves

Former Medtronic Executive Joins Baxter International

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.